CLTA anticorps (Internal Region)
-
- Antigène Voir toutes CLTA Anticorps
- CLTA (Clathrin, Light Chain A (CLTA))
-
Épitope
- Internal Region
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CLTA est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Fonction
- CTLA + CTLB
- Séquence
- CDFNPKSSKQ AKD
- Specificité
- This antibody is expected to recognize all reported isoforms of light chains a and b.
- Réactivité croisée
- Boeuf (Vache), Chien, Humain, Souris, Rat
- Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Classe de qualité
- Verified
- Immunogène
- Peptide with sequence CDFNPKSSKQAKD, from the internal region of the protein sequence according to NP_001824.1, NP_009027.1, NP_001070145.1, NP_001825.1, NP_009028.1.
- Isotype
- IgG
- Top Product
- Discover our top product CLTA Anticorps primaire
-
-
- Indications d'application
-
Immunohistochemistry: Paraffin embedded Human Spleen. Recommended concentration: 2.5 μg/mL.
Western Blot: Approx. 35 kDa and 22-23 kDa bands observed in Human Brain (Frontal Cortex) lysates (calculated MW of 23.2 kDa according to NP_001825.1). The observed molecular weight of ~35 kDa corresponds to earlier findings in literature with different anti
Peptide ELISA: antibody detection limit dilution 1:32000.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Minimize freezing and thawing.
- Stock
- -20 °C
- Stockage commentaire
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Antigène
- CLTA (Clathrin, Light Chain A (CLTA))
- Autre désignation
- CLTA (CLTA Produits)
- Synonymes
- anticorps lca, anticorps zgc:73358, anticorps wu:fb61d08, anticorps wu:fj48d06, anticorps CLTA, anticorps DDBDRAFT_0169251, anticorps DDBDRAFT_0191305, anticorps DDB_0169251, anticorps DDB_0191305, anticorps clc, anticorps LCA, anticorps LCA1, anticorps LCA2, anticorps LCA3, anticorps CLTA2, anticorps AV026556, anticorps Clathrin light chain, anticorps clathrin light chain A, anticorps clathrin, light chain A, anticorps clathrin, light chain (Lca), anticorps clathrin light chain, anticorps clathrin, light polypeptide (Lca), anticorps clic-1, anticorps clta, anticorps CLTA, anticorps CNI00580, anticorps LOC5567495, anticorps CLC1, anticorps CpipJ_CPIJ018056, anticorps PTRG_01988, anticorps PMAA_096950, anticorps SJAG_04517, anticorps TSTA_044110, anticorps PAS_chr1-4_0158, anticorps clc, anticorps Clta
- Sujet
- CLTA, CTLB, clathrin, light chain (Lca), LCA, clathrin, light polypeptide (Lca), clathrin, light polypeptide A, clathrin, light chain (Lcb), LCB
- ID gène
- 1211, 1212, 12757
- NCBI Accession
- NP_001824, NP_009027, NP_001070145, NP_001825, NP_009028
- Pathways
- EGFR Signaling Pathway, Neurotrophin Signaling Pathway, EGFR Downregulation
-